Dapagliflozin reduces the vulnerability of rats with pulmonary arterial hypertension-induced right heart failure to ventricular arrhythmia by restoring calcium handling
Release time:
1970-01-01
Wu J, Liu T, Shi S, Fan Z, Hiram R, Xiong F, Cui B, Su X, Chang R, Zhang W, Yan M, Tang Y, Huang H, Wu G, Huang C. Dapagliflozin reduces the vulnerability of rats with pulmonary arterial hypertension-induced right heart failure to ventricular arrhythmia by restoring calcium handling. Cardiovasc Diabetol. 2022 Sep 28;21(1):197. doi: 10.1186/s12933-022-01614-5. Erratum in: Cardiovasc Diabetol. 2022 Oct 31;21(1):224. doi: 10.1186/s12933-022-01669-4.
Activity Center